Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak-Reference-Cited by-同舟云学术

Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak

Published:2020-05-19 Issue:2 Volume:272 Page:e96-e97
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Thompson Carlie K.,Lee Minna K.,Baker Jennifer L.,Attai Deanna J.,DiNome Maggie L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference15 articles.

1. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis;Mauri;J Natl Cancer Inst,2005

2. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

3. Adjuvant capecitabine for breast cancer after preoperative chemotherapy;Masuda;N Engl J Med,2017

4. Trastuzumab emtansine for residual invasive HER2-positive breast cancer;Von MInckwith;N Engl J Med,2019

5. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics;Ellis;J Natl Cancer Inst,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Node‐Positive HR+, HER2− Breast Cancer (Nodal pCR and the Rate of ALND): A Systematic Review and Meta‐Analysis;The Breast Journal;2024-01

2. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021;Breast Cancer Research and Treatment;2023-08-16

3. Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches;Annals of Surgical Oncology;2023-07-19

4. COVID-19 and Breast Cancer: Analysis of Surgical Management of a Large Referral Center during the 2020–2021 Pandemic Period;Current Oncology;2023-05-05

5. Breast Cancer and SARS-Cov2: Lessons from a Pandemic;Anticancer Research;2023-04-25